RCUS
Arcus Biosciences Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$21.98
-0.72 ▼ -3.17%
🌙 3월 13일 6:16 PM ET (한국 3/14 07:16)
$21.97
+0.00 +0.00%
| Index | RUT | P/E | - | EPS (ttm) | -3.3 | Insider Own | 34.49% | Shs Outstand | 0.13B | Perf Week | -0.59% |
| Market Cap | 2.75B | Forward P/E | - | EPS next Y | 15% | Insider Trans | -1.21% | Shs Float | 0.08B | Perf Month | 2.9% |
| Enterprise Value | 1.97B | PEG | - | EPS next Q | -0.95 | Inst Own | 68.39% | Short Float | 11.28% | Perf Quarter | -13.46% |
| Income | -0.35B | P/S | 11.15 | EPS this Y | -20.43% | Inst Trans | 20.96% | Short Ratio | 6.7 | Perf Half Y | 91.13% |
| Sales | 0.25B | P/B | 4.36 | EPS next 5Y | 12.12% | ROA | -26.01% | Short Interest | 9.27M | Perf YTD | -7.76% |
| Book/sh | 5.04 | P/C | 2.81 | EPS past 3/5Y | 3.94% -7.95% | ROE | -63.26% | 52W High | -16.74% ($26.40) | Perf Year | 130.4% |
| Cash/sh | 7.83 | P/FCF | - | Sales past 3/5Y | 30.16% 26.08% | ROIC | -43.26% | 52W Low | 238.15% ($6.50) | Perf 3Y | 28.01% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -6.5% | Gross Margin | 95.95% | Volatility(W/M) | 6.7% 7.03% | Perf 5Y | -39.7% |
| Dividend TTM | - | EV/Sales | 7.98 | Sales Y/Y TTM | -4.26% | Oper. Margin | -156.28% | ATR (14) | 1.44 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 4.36 | EPS Q/Q | 12.74% | Profit Margin | -142.91% | RSI (14) | 50.5 | Recom | 1.55 |
| Dividend Gr. 3/5Y | - | Current Ratio | 4.36 | Sales Q/Q | 26.92% | SMA20 | 3.26% ($21.29) | Beta | 0.87 | Target Price | $33.8 |
| Payout | - | Debt/Eq | 0.31 | Earnings | 2000000 | SMA50 | 1.47% ($21.66) | Rel Volume | 0.85 | Prev Close | $22.7 |
| Employees | 601 | LT Debt/Eq | 0.29 | EPS/Sales Surpr. | 19.55% -7.59% | SMA200 | 35.7% ($16.2) | Avg Volume(3M) | 1.38M | Price | $21.98 |
| IPO | 2018/3/15 | Option/Short | Yes/Yes | Trades | 9234 | Volume | 1,173,180 | Change | -3.17% |
뉴스 로딩 중...